[Therapy of parasitic diseases of the nervous system].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D000965:Antimony / Q000627:therapeutic use; D001152:Arsenicals / Q000009:adverse effects / Q000627:therapeutic use; D002490:Central Nervous System / Q000601:surgery; D003551:Cysticercosis / Q000628:therapy; D004443:Echinococcosis / Q000628:therapy; D006801:Humans; D008288:Malaria / Q000628:therapy; D009422:Nervous System Diseases / Q000188:drug therapy / Q000628:therapy*; D010272:Parasitic Diseases / Q000188:drug therapy / Q000628:therapy*; D012552:Schistosomiasis / Q000628:therapy; D013449:Sulfonamides / Q000627:therapeutic use; D013644:Tartrates / Q000627:therapeutic use; D013997:Time Factors; D014123:Toxoplasmosis / Q000628:therapy; D014352:Trypanosomiasis / Q000628:therapy
D000900:Anti-Bacterial Agents; D000962:Antimalarials; D001152:Arsenicals; D013449:Sulfonamides; D013644:Tartrates; D000965:Antimony
Therapie der parasitären Erkrankungen des Nervensystems.